Chemoinformaics analysis of 3-METHOXY-2,5-DIMETHYLPYRAZINE
Molecular Weight | 138.17 | nRot | 1 |
Heavy Atom Molecular Weight | 128.09 | nRig | 6 |
Exact Molecular Weight | 138.079 | nRing | 1 |
Solubility: LogS | -0.603 | nHRing | 1 |
Solubility: LogP | 1.542 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 21.3599 |
nHD | 0 | BPOL | 14.0481 |
QED | 0.583 |
Synth | 2.348 |
Natural Product Likeliness | -1.292 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.003 |
HIA | 0.006 |
CACO-2 | -4.554 |
MDCK | 0.0000334 |
BBB | 0.949 |
PPB | 0.661968 |
VDSS | 1.145 |
FU | 0.286442 |
CYP1A2-inh | 0.712 |
CYP1A2-sub | 0.866 |
CYP2c19-inh | 0.026 |
CYP2c19-sub | 0.86 |
CYP2c9-inh | 0.003 |
CYP2c9-sub | 0.408 |
CYP2d6-inh | 0.009 |
CYP2d6-sub | 0.856 |
CYP3a4-inh | 0.017 |
CYP3a4-sub | 0.466 |
CL | 9.971 |
T12 | 0.493 |
hERG | 0.02 |
Ames | 0.037 |
ROA | 0.308 |
SkinSen | 0.655 |
Carcinogencity | 0.443 |
EI | 0.971 |
Respiratory | 0.487 |
NR-Aromatase | 0.008 |
Antiviral | No |
Prediction | 0.901072 |